Company Filing History:
1 out of 12 
1 out of 917 
Years Active: 2005-2010
Title: Keiko Kamei: Innovator in Medical Diagnostics
Introduction
Keiko Kamei is a prominent inventor based in Kumamoto, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the area of heparin-induced thrombocytopenia and thrombosis. With a total of 2 patents, her work has the potential to greatly impact patient care and treatment options.
Latest Patents
One of her latest patents focuses on compositions and methods useful for the diagnosis and treatment of heparin-induced thrombocytopenia/thrombosis. This invention includes compositions, kits, and methods that comprise a monoclonal antibody sharing key functional properties with polyclonal antibodies involved in the pathogenesis of heparin-induced thrombocytopenia/thrombosis (HIT/HITT) in mammals. The monoclonal antibody preferentially binds with a PF4/heparin complex, enhancing its effectiveness compared to binding with PF4 or heparin alone. Additionally, it binds specifically with PF4 in a complex with other glycosaminoglycans and activates platelets. This innovative approach is useful in diagnosing and treating HIT/HITT in mammals, and it also includes a humanized version of the monoclonal antibody along with a process for humanizing it.
Career Highlights
Throughout her career, Keiko Kamei has worked with notable organizations, including Science & Technology Corporation and Stc.unm. Her expertise in the field has allowed her to develop groundbreaking solutions that address critical medical challenges.
Collaborations
Keiko has collaborated with esteemed colleagues such as Gowthami M Arepally and Walter Kisiel. These partnerships have further enriched her research and development efforts.
Conclusion
Keiko Kamei's innovative work in medical diagnostics exemplifies the impact of dedicated inventors in advancing healthcare solutions. Her contributions are paving the way for improved diagnosis and treatment of serious medical conditions.